Company Logo

Gantenerumab

Agricultural Biotechnology

Updated on Feb 10, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for Gantenerumab with ID of: 4039159
Recombinant monoclonal antibody to Abeta. Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease. A phase I clinical trial has been conducted in 2006/07. Gantenerumab is currently being evaluated in a prodromal Alzheimer's Disease population in the Scarlet Road study, a global phase II study of approximately 360 subjects in 100 centers in 15 countries.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.